147 related articles for article (PubMed ID: 37780622)
1. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.
Li Z; Zhang H; Yan Y; Li X; Jia M; Zhou H; Lu X
Front Endocrinol (Lausanne); 2023; 14():1200855. PubMed ID: 37780622
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathologic characteristics of familial and sporadic papillary thyroid carcinoma in Turkish patients.
Sezer H; Demirkol MO; Yazici D; Kapran Y; Alagöl MF
Turk J Med Sci; 2020 Apr; 50(2):360-368. PubMed ID: 31999407
[TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
4. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.
Sung TY; Lee YM; Yoon JH; Chung KW; Hong SJ
World J Surg; 2015 Aug; 39(8):1930-5. PubMed ID: 25894401
[TBL] [Abstract][Full Text] [Related]
5. Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
Lee CR; Park S; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
Ann Surg Treat Res; 2017 Mar; 92(3):129-135. PubMed ID: 28289666
[TBL] [Abstract][Full Text] [Related]
6. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
Cao J; Chen C; Chen C; Wang QL; Ge MH
Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma.
Capezzone M; Fralassi N; Secchi C; Cantara S; Brilli L; Pilli T; Maino F; Forleo R; Pacini F; Cevenini G; Cartocci A; Castagna MG
Eur Thyroid J; 2020 Jul; 9(4):213-220. PubMed ID: 32903994
[TBL] [Abstract][Full Text] [Related]
9. [Biological characteristics and management of familial papillary thyroid carcinoma].
Zhao J; Yu Y; Xia TT; Liu YZ; Wei SF; Zheng XQ; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 46(11):897-900. PubMed ID: 22335974
[TBL] [Abstract][Full Text] [Related]
10. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
13. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
[TBL] [Abstract][Full Text] [Related]
14. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
Song RY; Kim HS; Kang KH
World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
[TBL] [Abstract][Full Text] [Related]
15. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
[No Abstract] [Full Text] [Related]
17. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
18. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
19. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J
Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442
[TBL] [Abstract][Full Text] [Related]
20. Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kindreds With Two Affected Members.
Capezzone M; Sagnella A; Pilli T; Maino F; Forleo R; Cantara S; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2021 Jan; 106(2):e855-e865. PubMed ID: 33175120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
